| [1] |
Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.Research progress of myeloid-derived suppressor cells in tumor angiogenesis[J]. Journal of International Oncology, 2024, 51(1): 50-54. |
| [2] |
Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462. |
| [3] |
Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.Current status of research on exosomes in malignancies[J]. Journal of International Oncology, 2023, 50(8): 484-488. |
| [4] |
Zheng Jing, Yao Sheng, Shen Wenjie, Sun Zhijia, Zhao Hui, Fu Yan, Gao Ke, Du Nan.Clinical study of intraperitoneal infusion of bevacizumab combined with albumin paclitaxel and carboplatin in carcinomatous peritoneal adhesion from ovarian cancer[J]. Journal of International Oncology, 2021, 48(11): 660-665. |
| [5] |
Qi Ruili, Wang Huaqing.Research progress of tumor vascular targeting drugs combined with PD-1/PD-L1 antibody in the treatment of digestive system tumors[J]. Journal of International Oncology, 2019, 46(12): 750-754. |
| [6] |
Ke Bin, Li Bin, Liang Han.Research advances of EDIL3 in tumor[J]. Journal of International Oncology, 2019, 46(11): 678-681. |
| [7] |
Feng Yue, Yu Jingping, Wang Jianlin.Application of antiangiogenesis therapy in the radiotherapy of esophageal cancer[J]. Journal of International Oncology, 2017, 44(6): 468-. |
| [8] |
WANG Mei, JIANG Xiao-Dong.The role of epigenetics on antiangiogenesis therapy[J]. Journal of International Oncology, 2017, 44(5): 380-382. |
| [9] |
Hou Xiaoyun, Chu Yanjun..The mechanism of RNA interference for hepatocellular carcinoma treatment[J]. Journal of International Oncology, 2017, 44(4): 297-299. |
| [10] |
FAN Ze-Ying, ZHANG Xiao-Dong, CHEN Hong-Qing.The mechanism of itraconazole as an anticancer agent[J]. Journal of International Oncology, 2017, 44(2): 136-138. |
| [11] |
Qu Liyan, Kang Xiaoyan, Song Xia.Appliation of the combination of antiangiogenic agents and EGFR-TKIs in advanced NSCLC treatment[J]. Journal of International Oncology, 2017, 44(1): 57-59. |
| [12] |
SUN Ning-Bo, WANG Wei, ZHU Qiang, CAO Ming, JIANG Zhong-Min, ZANG Qi.Inhibitory effect of dexamethasone on residual Lewis lung cancer cells in mice after palliative surgery[J]. Journal of International Oncology, 2016, 43(2): 81-. |
| [13] |
SHANG Yi-Tai, LI Xiao-Jiang.Progress on antiangiogenesis treating head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2015, 42(8): 619-621. |
| [14] |
Zhang Yuemeng, Sun Shanshan, Liu Wenzhi, Gao Wencang.Expression and effect of related factors of lymphangiogenesis in colorectal cancer[J]. Journal of International Oncology, 2015, 42(7): 542-544. |
| [15] |
WU Zheng-Qi-；Zhang-Zhi-Yi-；Wang-Hui-Juan-；Liu-Xiao-Jun.Research progress of three antiangiogenic agents in the treatment of advanced colorectal cancer[J]. Journal of International Oncology, 2015, 42(4): 301-304. |
